Terms: = Brain cancer AND PRKAR1A, DKFZp779L0468, 5573, ENSG00000108946, PRKAR1, P10644, CNC1, PKR1, MGC17251, PPNAD1, TSE1, CNC, CAR AND Prognosis
68 results:
1. B7-H3 Expression in Breast cancer and brain Metastasis.
Joshi V; Beecher K; Lim M; Stacey A; Feng Y; Jat PS; Duijf PHG; Simpson PT; Lakhani SR; McCart Reed AE
Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612786
[TBL] [Abstract] [Full Text] [Related]
2. Mesenchymal-Stem-Cell-Based Therapy against Gliomas.
Santillán-Guaján SM; Shahi MH; Castresana JS
Cells; 2024 Apr; 13(7):. PubMed ID: 38607056
[TBL] [Abstract] [Full Text] [Related]
3. Identification of genetic modifiers enhancing B7-H3-targeting car T cell therapy against glioblastoma through large-scale CRISPRi screening.
Li X; Sun S; Zhang W; Liang Z; Fang Y; Sun T; Wan Y; Ma X; Zhang S; Xu Y; Tian R
J Exp Clin Cancer Res; 2024 Apr; 43(1):95. PubMed ID: 38561797
[TBL] [Abstract] [Full Text] [Related]
4. [New treatment strategies for primary lymphoma of the central nervous system].
Seidel S; Kaulen L; von Baumgarten L
Nervenarzt; 2024 Feb; 95(2):117-124. PubMed ID: 37910181
[TBL] [Abstract] [Full Text] [Related]
5. Glioblastoma Immunotherapy: A Systematic Review of the Present Strategies and Prospects for Advancements.
Agosti E; Zeppieri M; De Maria L; Tedeschi C; Fontanella MM; Panciani PP; Ius T
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894718
[TBL] [Abstract] [Full Text] [Related]
6. Global research trends in immunotherapy for glioma: a comprehensive visualization and bibliometric analysis.
Zhang HY; Yu HY; Zhao GX; Jiang XZ; Gao G; Wei BJ
Front Endocrinol (Lausanne); 2023; 14():1273634. PubMed ID: 37867521
[TBL] [Abstract] [Full Text] [Related]
7. New hopes in relapsed refractory primary central nervous system lymphoma.
Calimeri T; Steidl C; Fiore P; Ferreri AJM
Curr Opin Oncol; 2023 Sep; 35(5):364-372. PubMed ID: 37551946
[TBL] [Abstract] [Full Text] [Related]
8. Local immunotherapy of glioblastoma: A comprehensive review of the concept.
Sabahi M; Salehipour A; Bazl MSY; Rezaei N; Mansouri A; Borghei-Razavi H
J Neuroimmunol; 2023 Aug; 381():578146. PubMed ID: 37451079
[TBL] [Abstract] [Full Text] [Related]
9. Recent advances and future challenges of tumor vaccination therapy for recurrent glioblastoma.
Zhao B; Wu J; Li H; Wang Y; Wang Y; Xing H; Wang Y; Ma W
Cell Commun Signal; 2023 Apr; 21(1):74. PubMed ID: 37046332
[TBL] [Abstract] [Full Text] [Related]
10. The peculiar challenge of bringing car-T cells into the brain: Perspectives in the clinical application to the treatment of pediatric central nervous system tumors.
Del Baldo G; Del Bufalo F; Pinacchio C; Carai A; Quintarelli C; De Angelis B; Merli P; Cacchione A; Locatelli F; Mastronuzzi A
Front Immunol; 2023; 14():1142597. PubMed ID: 37025994
[TBL] [Abstract] [Full Text] [Related]
11. car t-cell therapy in BOlogNa-NEUrotoxicity TReatment and Assessment in Lymphoma (carBON-NEUTRAL): proposed protocol and results from an Italian study.
Pensato U; Amore G; Muccioli L; Sammali S; Rondelli F; Rinaldi R; D'Angelo R; Nicodemo M; Mondini S; Sambati L; Asioli GM; Rossi S; Santoro R; Cretella L; Ferrari S; Spinardi L; Faccioli L; Fanti S; Paccagnella A; Pierucci E; Casadei B; Pellegrini C; Zinzani PL; Bonafè M; Cortelli P; Bonifazi F; Guarino M
J Neurol; 2023 May; 270(5):2659-2673. PubMed ID: 36869888
[TBL] [Abstract] [Full Text] [Related]
12. car T-cells to treat brain tumors.
Guzman G; Pellot K; Reed MR; Rodriguez A
Brain Res Bull; 2023 May; 196():76-98. PubMed ID: 36841424
[TBL] [Abstract] [Full Text] [Related]
13. Immunotherapy as a New Therapeutic Approach for brain and Spinal Cord Tumors.
Medikonda R; Pant A; Lim M
Adv Exp Med Biol; 2023; 1394():73-84. PubMed ID: 36587382
[TBL] [Abstract] [Full Text] [Related]
14. Immunotherapy for Pediatric brain and Spine Tumors: Current State and Future Directions.
Estevez-Ordonez D; Gary SE; Atchley TJ; Maleknia PD; George JA; Laskay NMB; Gross EG; Devulapalli RK; Johnston JM
Pediatr Neurosurg; 2023; 58(5):313-336. PubMed ID: 36549282
[TBL] [Abstract] [Full Text] [Related]
15. Advances in immunotherapy for glioblastoma multiforme.
Mahmoud AB; Ajina R; Aref S; Darwish M; Alsayb M; Taher M; AlSharif SA; Hashem AM; Alkayyal AA
Front Immunol; 2022; 13():944452. PubMed ID: 36311781
[TBL] [Abstract] [Full Text] [Related]
16. Neoantigen discovery and applications in glioblastoma: An immunotherapy perspective.
Wang C; Yu M; Zhang W
Cancer Lett; 2022 Dec; 550():215945. PubMed ID: 36216148
[TBL] [Abstract] [Full Text] [Related]
17. Clinical utility of car T cell therapy in brain tumors: Lessons learned from the past, current evidence and the future stakes.
Chatterjee A; Asija S; Yadav S; Purwar R; Goda JS
Int Rev Immunol; 2022; 41(6):606-624. PubMed ID: 36191126
[TBL] [Abstract] [Full Text] [Related]
18. Immunotherapy approaches for the treatment of diffuse midline gliomas.
Bernstock JD; Hoffman SE; Kappel AD; Valdes PA; Essayed W; Klinger NV; Kang KD; Totsch SK; Olsen HE; Schlappi CW; Filipski K; Gessler FA; Baird L; Filbin MG; Hashizume R; Becher OJ; Friedman GK
Oncoimmunology; 2022; 11(1):2124058. PubMed ID: 36185807
[TBL] [Abstract] [Full Text] [Related]
19. Correlation between C-reactive protein/albumin ratio and prognosis in patients with lung adenocarcinoma.
Jia-Min Z; Wei D; Ye L; Xiang-Tao P
J Int Med Res; 2022 Jun; 50(6):3000605221105372. PubMed ID: 35730330
[TBL] [Abstract] [Full Text] [Related]
20. Nanomedicines and cell-based therapies for embryonal tumors of the nervous system.
El Moukhtari SH; Garbayo E; Fernández-Teijeiro A; Rodríguez-Nogales C; Couvreur P; Blanco-Prieto MJ
J Control Release; 2022 Aug; 348():553-571. PubMed ID: 35705114
[TBL] [Abstract] [Full Text] [Related]
[Next]
